Ulcerative Colitis Clinical Study

ExiGem

The ExiGem Study is now enrolling.

Ulcerative colitis is a chronic, relapsing, inflammatory disorder of the gastrointestinal (GI) tract characterized by inflammation and ulcers limited to the colon. If you have been diagnosed with moderate to severely active ulcerative colitis, you may be eligible to participate in a clinical study evaluating an investigational treatment.

To see if the ExiGem Study is right for you, please contact us below.

Location: MNGI Digestive Health, Plymouth Clinic

Physician Investigator: Dr. Campbell

Study Coordinator: Tyler Pham

 

Diagnosed with Ulcerative Colitis and Considering Non-Drug Treatment?

MNGI Digestive Health and Minnesota Urology are recruiting patients diagnosed with ulcerative colitis (UC) for a new clinical study that is evaluating how effective sacral nerve modulation is for the treatment of UC.

Sacral nerve modulation is FDA-approved to treat overactive bladder and fecal incontinence. Patients who qualify for the study will have a minimally invasive procedure to have a small medical device implanted. Patients will be closely monitored to see how well the device helps manage their UC symptoms.

Subjects can receive study stipends to help compensate them for their time and travel to study visit appointments that they complete.  

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.

CAPTCHA
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.